Abstract
Uveitis is uncommon in patients with multiple sclerosis (MS), but the link between the two entities is clearly established. While a common etiology or pathologic process remains unknown, shared human leukocyte antigens suggest a genetic predisposition. The treatment for MS‑associated uveitis is not distinct from treatment of other types of noninfectious uveitis, but interferons may serve as a common therapeutic avenue for both CNS and eye disease. Further study is needed to better understand MS-associated uveitis and its link to demyelinating CNS disease.
Financial & competing interests disclosure
The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.
No writing assistance was utilized in the production of this manuscript.